Skip to main content
. Author manuscript; available in PMC: 2018 Aug 9.
Published in final edited form as: Atherosclerosis. 2016 Nov 12;256:100–104. doi: 10.1016/j.atherosclerosis.2016.11.011

Table 2. Study vitamin D levels.

Vitamin D levels (ng/mL) before and after statin and placebo therapy in patients with and without confirmed SAMS.

Confirmed (n=43) Not confirmed (n=77)
Pre-placebo 30.6 ± 10.3 31.9 ± 11.5
Post-placebo 31.5 ± 11.3 31.6 ± 11.6
Δ placebo 0.5 ± 4.7 −0.3 ± 5.3
Pre-statin 31.7 ± 12.1 31.5 ± 10.3
Post-statin 31.4 ± 10.8 31.8 ± 10.7
Δ statin 0.3 ± 5.9 0.2 ± 8.3

Δ indicates difference between post- to pre-levels. There were no significant differences between groups.